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Abstract
Complementary alternative health care presents fascinating challenges and opportunities for health policy and
research - from issues of definition to training and licensing, to insurance reimbursement and evidence regarding
clinical efficacy and outcomes. Complementary alternative health care is utilized by a substantial proportion of the
population both now and likely in the future and requires serious health policy consideration.
This is a commentary on http://www.ijhpr.org/content/1/1/7/.
Commentary
Complementary alternative health care (CAHC) presents
fascinating challenges and opportunities for health pol-
icy and research - from issues of definition to training
and licensing, to insurance reimbursement and evidence
regarding clinical efficacy and outcomes. The article by
Shuval and Averbuch [1] provides a remarkable over-
view of developments in this field in Israel, a country
where such practices are both widespread and main-
stream. As the authors note, over 1.7 million visits are
estimated to take place annually in a country of less
than 8 million people - and 65% of CAM services in
Israel occur and are integrated into the public sector
through the major health (sick) funds.
Clearly defining complementary alternative health care
is the likely starting point for any discussion of this
topic and, like many aspects of CAHC, it is filled with
controversy. Although complementary and alternative
health care is more comprehensive than the commonly
used term complementary and alternative medicine
(CAM), the latter is utilized in the article to refer to
array the plethora of “non-conventional health practices”
frequently used in Western societies. Even the question
of what is CAM or if CAM even exists is a topic of
debate. As noted by the NIH National Center for Com-
plementary and Alternative Medicine, “Complementary
and alternative medicine (CAM) is the term for medical
products and practices that are not part of standard
care.” [2,3] This definition is one of exclusion -
treatments that are not standard are thus considered
alternative if used instead of standard ones or comple-
mentary if they are used in tandem with standard care.
What constitutes “standard care” in any society is
dynamic over time and varies widely from country to
country based on everything from ever changing laws
and regulations to payment mechanisms and even immi-
gration patterns.
For example, treatments such as osteopathic or chiro-
practic manipulation in the United States have entered
the mainstream over the past few decades, with numer-
ous state laws, licensing of practitioners, and third party
insurance payments. These acts have ensured that osteo-
pathy and chiropractic have been virtually enshrined in
the “standard care” category. Similarly, in parts of Eur-
ope, homeopathy has been included in standard care,
something that has been rarely if ever broached in the
U.S. Immigrant ethnic groups, especially those from less
developed nations, often bring their traditional healing
traditions with them to their host countries; however,
strictly speaking such practices only exist the realm of
“traditional medicine:” and enter the realm of CAM
when Westerners from outside the ethnic group utilize
them.
Other methods of definition have focused on the clas-
sification of the literally hundreds or thousands of health
practices by modality or by theoretical roots. Others
have skirted the issues of classification, focusing instead
on efficacy of medical and therapeutic practices. The
question here becomes not one of conventional or non-
conventional, but rather, does the therapy in question
work?, i.e., does it have evidence of scientifically tested
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effectiveness. Shuval and Averbuch [1] also point out
that the definition of bio-medicine versus CAM is in
part defined by what is taught in medical schools. In
Israel, as in many countries, the teaching of CAM never
makes it beyond medical school elective options, if it
enters the curriculum at all.
There are a host of other key issues regarding CAM
that Shuval and Averbuch [1] cover in their article that
should be of interest to the broad health policy and
health care audience. One important issue is govern-
mental regulation and control. As Shuval and Averbuch
[1] note, despite the widespread use of CAM practices
in Israel, there is relatively little governmental control
and, to date, no formal jurisdictional regulation or licen-
sing procedures have been established. Though often
ascribed to the domination of bio-medicine in Israel,
other important factors that have resulted in this regula-
tory chasm may be the sheer number and literal cacoph-
ony of treatment modalities, providers, and training
standards. Having done research on CAM in Israel in
the past and recently informally sampled CAM in two
areas in Israel, I am impressed by the spectrum of prac-
tices that vary from common choices such as acupunc-
ture to offshoots of esoteric movement therapies to
spirit mediums. Regulating and controlling such a range
of therapeutic modalities would be challenging, if not
impossible.
The authors’ conclusion will have to withstand the test
of time: “CAM is here to stay and its use is likely to
increase in Israel in future years.” My sense is that this
is likely true, though the form in which it manifests
itself in the future may be starkly different than what we
see today. As the authors suggest, this article should be
“useful to health policy planners in other countries in
which CAM provides increasing portions of health
care”, though Israeli health planners may themselves
need to learn its lessons.
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